165 related articles for article (PubMed ID: 4066206)
41. Relationship between multiple forms of plasminogen activator in human breast tumors and plasma and the presence of metastases in lymph nodes.
Colombi M; Barlati S; Magdelenat H; Fiszer-Szafarz B
Cancer Res; 1984 Jul; 44(7):2971-5. PubMed ID: 6539166
[TBL] [Abstract][Full Text] [Related]
42. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.
De Petro G; Copeta A; Barlati S
Exp Cell Res; 1994 Jul; 213(1):286-94. PubMed ID: 8020601
[TBL] [Abstract][Full Text] [Related]
43. Human primary colon carcinomas xenografted into nude mice. I. Characterization of plasminogen activators expressed by primary tumors and their xenografts.
Cajot JF; Sordat B; Kruithof EK; Bachmann F
J Natl Cancer Inst; 1986 Sep; 77(3):703-12. PubMed ID: 3091899
[TBL] [Abstract][Full Text] [Related]
44. Localization and immunological characterization of plasminogen activators in human prostate tissue.
Kirchheimer J; Binder BR
Haemostasis; 1983; 13(6):358-62. PubMed ID: 6199265
[TBL] [Abstract][Full Text] [Related]
45. Plasminogen activator in human tears.
Stevens JD; Marshall JM; Benjamin L; Cederholm-Williams SA; Bron AJ
Eye (Lond); 1992; 6 ( Pt 6)():653-8. PubMed ID: 1289146
[TBL] [Abstract][Full Text] [Related]
46. Plasminogen activators in alveolar bone in man.
Björlin G; Ljungnér H; Astedt B
Acta Odontol Scand; 1986 Jun; 44(3):173-5. PubMed ID: 3461663
[TBL] [Abstract][Full Text] [Related]
47. Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report.
Duffy MJ; O'Grady P; Devaney D; O'Siorain L; Fennelly JJ; Lijnen HJ
Cancer; 1988 Aug; 62(3):531-3. PubMed ID: 3134120
[TBL] [Abstract][Full Text] [Related]
48. Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.
Sier CF; Verspaget HW; Griffioen G; Ganesh S; Vloedgraven HJ; Lamers CB
Gut; 1993 Jan; 34(1):80-5. PubMed ID: 8432457
[TBL] [Abstract][Full Text] [Related]
49. Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity.
Camiolo SM; Markus G; Evers JL; Hobika GH; DePasquale JL; Beckley S; Grimaldi JP
Int J Cancer; 1981 Feb; 27(2):191-8. PubMed ID: 6169657
[TBL] [Abstract][Full Text] [Related]
50. Plasminogen activators in human gastric cancers: correlation with DNA ploidy and immunohistochemical staining.
Takai S; Yamamura M; Tanaka K; Kawanishi H; Tsuji M; Nakane Y; Hioki K; Yamamoto M
Int J Cancer; 1991 Apr; 48(1):20-7. PubMed ID: 1902201
[TBL] [Abstract][Full Text] [Related]
51. Plasma urokinase-type plasminogen activator correlates to bone scintigraphy in prostatic carcinoma.
Hienert G; Kirchheimer JC; Christ G; Pflüger H; Binder BR
Eur Urol; 1988; 15(3-4):256-8. PubMed ID: 3145889
[TBL] [Abstract][Full Text] [Related]
52. [The study of plasminogen activator in renal cell carcinoma with special remarks on urokinase type plasminogen activator].
Hata M
Nihon Hinyokika Gakkai Zasshi; 1989 Nov; 80(11):1558-65. PubMed ID: 2512407
[TBL] [Abstract][Full Text] [Related]
53. Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies.
Hart CA; Scott LJ; Bagley S; Bryden AA; Clarke NW; Lang SH
Br J Cancer; 2002 Apr; 86(7):1136-42. PubMed ID: 11953862
[TBL] [Abstract][Full Text] [Related]
54. Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators.
Kopitar M; Rozman B; Babnik J; Turk V; Mullins DE; Wun TC
Thromb Haemost; 1985 Dec; 54(4):750-5. PubMed ID: 3879018
[TBL] [Abstract][Full Text] [Related]
55. Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: increased PA activity correlates with biologically aggressive behavior.
Keer HN; Gaylis FD; Kozlowski JM; Kwaan HC; Bauer KD; Sinha AA; Wilson MJ
Prostate; 1991; 18(3):201-14. PubMed ID: 1902292
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical localization of urokinase-type plasminogen activator in Sertoli cells and tissue-type plasminogen activator in spermatogenic cells in the rat seminiferous epithelium.
Vihko KK; Kristensen P; Danø K; Parvinen M
Dev Biol; 1988 Mar; 126(1):150-5. PubMed ID: 3125078
[TBL] [Abstract][Full Text] [Related]
57. Tissue plasminogen activator activity in prostatic cancer.
Köller A; Kirchheimer J; Pflüger H; Binder BR
Eur Urol; 1984; 10(6):389-94. PubMed ID: 6085049
[TBL] [Abstract][Full Text] [Related]
58. Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.
de Bruin PA; Verspaget HW; Griffioen G; Verheijen JH; Dooijewaard G; Lamers CB
Br J Cancer; 1989 Sep; 60(3):397-400. PubMed ID: 2506920
[TBL] [Abstract][Full Text] [Related]
59. Plasminogen activators in human xenografted oro-pharyngeal squamous cell carcinomas.
Björlin G; Ljungnér H; Wennerberg J; Astedt B
Acta Otolaryngol; 1987; 104(5-6):568-72. PubMed ID: 3434279
[TBL] [Abstract][Full Text] [Related]
60. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo.
Grøndahl-Hansen J; Lund LR; Ralfkiaer E; Ottevanger V; Danø K
J Invest Dermatol; 1988 Jun; 90(6):790-5. PubMed ID: 3131440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
